Florida Financial Advisors LLC Has $1.30 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Florida Financial Advisors LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,572 shares of the healthcare conglomerate’s stock after selling 420 shares during the period. Florida Financial Advisors LLC’s holdings in UnitedHealth Group were worth $1,301,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. Potentia Wealth purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $248,000. PKS Advisory Services LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $645,000. Signature Estate & Investment Advisors LLC raised its holdings in shares of UnitedHealth Group by 13.9% during the 4th quarter. Signature Estate & Investment Advisors LLC now owns 3,686 shares of the healthcare conglomerate’s stock valued at $1,864,000 after purchasing an additional 450 shares in the last quarter. Syverson Strege & Co boosted its holdings in UnitedHealth Group by 31.1% in the fourth quarter. Syverson Strege & Co now owns 868 shares of the healthcare conglomerate’s stock worth $439,000 after purchasing an additional 206 shares in the last quarter. Finally, Heritage Wealth Management Inc. CA raised its holdings in UnitedHealth Group by 50.8% during the fourth quarter. Heritage Wealth Management Inc. CA now owns 1,095 shares of the healthcare conglomerate’s stock valued at $554,000 after buying an additional 369 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts recently weighed in on UNH shares. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $516.94 on Tuesday. The firm has a 50 day moving average of $509.71 and a 200-day moving average of $546.15. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market capitalization of $472.85 billion, a P/E ratio of 33.35, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company posted $5.83 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.